Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
474 hedge funds and large institutions have $13B invested in Abiomed Inc in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 163 increasing their positions, 179 reducing their positions, and 49 closing their positions.
71% more call options, than puts
Call options by funds: $106M | Put options by funds: $61.8M
1% less capital invested
Capital invested by funds: $13.1B → $13B (-$186M)
9% less repeat investments, than reductions
Existing positions increased: 163 | Existing positions reduced: 179
3% less funds holding
Funds holding: 487 → 474 (-13)
16% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 49
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$185M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$145M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$58.6M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$24.9M |
| 5 |
Two Sigma Advisers
New York
|
+$22.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$46.4M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$42.2M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$38.3M |
| 4 |
Renaissance Technologies
New York
|
-$31M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$29M |
ABMD Hedge Fund Activity: Q2 2021 in Review
474 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2021, worth a combined $13B — down 1.4% from $13.1B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of ABMD and 41 opened new positions — a net loss of 8 holders — while 179 trimmed existing stakes and 163 added.
The largest buyer was Ownership Capital B.V., opening a new position worth an estimated $185M. The largest seller was Adage Capital Partners, cutting an estimated $46.4M.
- 474 institutional investors held Abiomed Inc (ABMD) as of Q2 2021, down from 487 in Q1 2021.
- Funds reported $13B of Abiomed Inc stock for Q2 2021, down 1.4% quarter-over-quarter.
- 41 funds opened new Abiomed Inc positions in Q2 2021 and 49 closed out, a net change of -8 holders.
- The largest Abiomed Inc buyer in Q2 2021 was Ownership Capital B.V., an estimated $185M added.
- The largest Abiomed Inc seller in Q2 2021 was Adage Capital Partners, an estimated $46.4M sold.
Based on aggregated 13F filings for Q2 2021.